{"id":81935,"date":"2026-01-09T22:38:06","date_gmt":"2026-01-09T22:38:06","guid":{"rendered":"https:\/\/www.europesays.com\/ee\/81935\/"},"modified":"2026-01-09T22:38:06","modified_gmt":"2026-01-09T22:38:06","slug":"kas-retseptiravimid-voivad-eestis-pohjustada-soltuvuskriisi","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/ee\/81935\/","title":{"rendered":"kas retseptiravimid v\u00f5ivad Eestis p\u00f5hjustada s\u00f5ltuvuskriisi?"},"content":{"rendered":"<p>\n                Steven Ilves, Tartu \u00fclikool magistrant \u00f5ppekaval \u201cMuutuste juhtimine \u00fchiskonnas\u201d, 10. jaanuar 2026\n            <\/p>\n<p>Vastus: jah, oks\u00fckodooni ja teiste retseptopioidide laialdane kasutamine Euroopas ja ka Eestis on suurendanud s\u00f5ltuvust, haiglaravi ja surmajuhtumite arvu.<\/p>\n<p data-block-id=\"48E_ZuKG\">Euroopas on pead t\u00f5stmas t\u00f5sisem probleem opioidsete valuvaigistitega, eelk\u00f5ige oks\u00fckodooniga, mida m\u00e4\u00e4ratakse kroonilise ja \u00e4geda valu leevendamiseks. Alates 2000ndatest on oks\u00fckodooni kasutamine Euroopas j\u00e4rsult kasvanud, mis on kaasa toonud s\u00f5ltuvusprobleemide sagenemise, haiglaravi vajaduse ja surmajuhtumite kasvu.<\/p>\n<p data-block-id=\"t1quZs8I\">N\u00e4iteks Rootsis kasvas oks\u00fckodooni retseptide arv 2006\u20132018 k\u00fcmnekordselt ja samal perioodil registreeriti 756 ravimiga seotud surmajuhtumit. \u0160veitsis suurenes oks\u00fckodooniga seotud m\u00fcrgistusteabek\u00f5nede arv 2933% v\u00f5rra. Viimase k\u00fcmnendi jooksul neljakordistus Hollandis tarvitajate arv ning Prantsusmaal on oks\u00fckodoon t\u00f5usnud \u00fcheks peamiseks v\u00e4\u00e4rkasutatavaks ravimiks, eriti noorte seas. Lisaks sellele on Euroopa ebaseaduslikul turul oks\u00fckodooni konfiskeerimised vahemikus 2018\u20132021 neljakordistunud.<\/p>\n","protected":false},"excerpt":{"rendered":"Steven Ilves, Tartu \u00fclikool magistrant \u00f5ppekaval \u201cMuutuste juhtimine \u00fchiskonnas\u201d, 10. jaanuar 2026 Vastus: jah, oks\u00fckodooni ja teiste retseptopioidide&hellip;\n","protected":false},"author":2,"featured_media":81936,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[16],"tags":[464,37,33,35,173,34,36,140],"class_list":{"0":"post-81935","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-meelelahutus","8":"tag-digileht-ohtuleht-ee","9":"tag-ee","10":"tag-eesti","11":"tag-eesti-keel","12":"tag-entertainment","13":"tag-estonia","14":"tag-estonian","15":"tag-meelelahutus"},"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@ee\/115867543372303050","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/ee\/wp-json\/wp\/v2\/posts\/81935","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/ee\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/ee\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ee\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ee\/wp-json\/wp\/v2\/comments?post=81935"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/ee\/wp-json\/wp\/v2\/posts\/81935\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ee\/wp-json\/wp\/v2\/media\/81936"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/ee\/wp-json\/wp\/v2\/media?parent=81935"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/ee\/wp-json\/wp\/v2\/categories?post=81935"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/ee\/wp-json\/wp\/v2\/tags?post=81935"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}